
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP updates guidance on pediatric iron deficiency screening and treatment
2
FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis
3
Pediatric clinical trial update: Q2 2026
4
Sequential bilateral TMS linked to improvement in youth treatment-resistant depression
5




